Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001862734-26-000002

Director acquired 3,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KANTOFF AARON Director 2026-03-28 Option exercise +3,166 6,333 D
Derivatives
KANTOFF AARON Director 2026-03-28 Option exercise · Restricted Stock Units −3,166 3,167 D
Loading xslF345X06/form4-03312026_080342.xml…